PUBLICATION

Immunotherapy Targeting the C-Terminal Domain of TDP-43 Decreases Neuropathology and Confers Neuroprotection in Mouse Models of ALS/FTD

February 20, 2023
Read More
INDUSTRY NEWS

2023 Pharma Predictions

February 9, 2023
Read More
INDUSTRY NEWS

PsychoGenics CEO Explores CNS Drug Development Trends

February 4, 2023
Read More
INDUSTRY NEWS

What Will the 2023 Drug Discovery Landscape Look Like?

January 24, 2023
Read More
INDUSTRY NEWS

Executives Shares 7 Life Sciences Predictions to Watch in 2023

January 13, 2023
Read More
INDUSTRY NEWS

Changing Drug Discovery for Neuropsychiatric Disorders with Phenotypic Screens

November 23, 2022
Read More
INDUSTRY NEWS

Why the TAAR1 Agonist Ulotaront Holds Promise for Schizophrenia

November 22, 2022
Read More
INDUSTRY NEWS

Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics

November 18, 2022
Read More
INDUSTRY NEWS

Harnessing the Power of AI Technology for Drug Discovery Treatments

November 16, 2022
Read More